205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-7.92%
Revenue decline while MCHP shows 5.23% growth. Joel Greenblatt would examine competitive position erosion.
-6.23%
Cost reduction while MCHP shows 4.23% growth. Joel Greenblatt would examine competitive advantage.
-9.52%
Gross profit decline while MCHP shows 5.90% growth. Joel Greenblatt would examine competitive position.
-1.74%
Margin decline while MCHP shows 0.64% expansion. Joel Greenblatt would examine competitive position.
-2.46%
R&D reduction while MCHP shows 4.88% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.00%
Operating expenses reduction while MCHP shows 6.13% growth. Joel Greenblatt would examine advantage.
-4.73%
Total costs reduction while MCHP shows 4.93% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-6.51%
D&A reduction while MCHP shows 1.81% growth. Joel Greenblatt would examine efficiency.
-14.87%
EBITDA decline while MCHP shows 38.35% growth. Joel Greenblatt would examine position.
-7.55%
EBITDA margin decline while MCHP shows 31.48% growth. Joel Greenblatt would examine position.
-17.63%
Operating income decline while MCHP shows 5.75% growth. Joel Greenblatt would examine position.
-10.55%
Operating margin decline while MCHP shows 0.50% growth. Joel Greenblatt would examine position.
29.63%
Other expenses growth above 1.5x MCHP's 17.65%. Michael Burry would check for concerning trends.
-15.04%
Pre-tax income decline while MCHP shows 6.83% growth. Joel Greenblatt would examine position.
-7.73%
Pre-tax margin decline while MCHP shows 1.53% growth. Joel Greenblatt would examine position.
-44.30%
Both companies reducing tax expense. Martin Whitman would check patterns.
-4.84%
Net income decline while MCHP shows 88.34% growth. Joel Greenblatt would examine position.
3.35%
Net margin growth below 50% of MCHP's 78.98%. Michael Burry would check for structural issues.
-2.13%
EPS decline while MCHP shows 89.47% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-2.52%
Share count reduction while MCHP shows 0.43% change. Joel Greenblatt would examine strategy.
-2.41%
Both companies reducing diluted shares. Martin Whitman would check patterns.